How Medium Biosciences is Building the Future of Protein Therapeutics

AI-powered Drug Discovery Machine Learning Biotech AI

📉 What Happened

Company is active

Event Year: 2021

📉 What Happened

Company is active

Event Year: 2021

📄 Long Description

Medium Biosciences is dedicated to the development of functional, therapeutic proteins through the application of advanced artificial intelligence models and innovative assay techniques. By leveraging AI, the company aims to design and engineer novel proteins with therapeutic potential, addressing unmet needs in the healthcare sector. This approach allows for the creation of targeted and effective protein-based therapies.

📄 Long Description

Medium Biosciences is dedicated to the development of functional, therapeutic proteins through the application of advanced artificial intelligence models and innovative assay techniques. By leveraging AI, the company aims to design and engineer novel proteins with therapeutic potential, addressing unmet needs in the healthcare sector. This approach allows for the creation of targeted and effective protein-based therapies.

💰 Funding

Total Raised: Unknown (Y Combinator backed)

Last Round: Summer 2021

Investors:

Y Combinator

💰 Funding

Total Raised: Unknown (Y Combinator backed)

Last Round: Summer 2021

Investors:

Y Combinator

Business Model

Healthcare

Business Model

Healthcare

Target Customers

Healthcare -> Therapeutics

Target Customers

Healthcare -> Therapeutics

Signals

Team size: 6

Hiring: No

Signals

Team size: 6

Hiring: No

Sources

[1]https://www.ycombinator.com/companies/medium-biosciences

Sources

[1]https://www.ycombinator.com/companies/medium-biosciences